196 related articles for article (PubMed ID: 20837718)
1. False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial).
Johns LE; Moss SM;
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2758-64. PubMed ID: 20837718
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance.
Johns LE; Moss SM;
J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944
[TBL] [Abstract][Full Text] [Related]
3. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.
Otten JDM; Fracheboud J; den Heeten GJ; Otto SJ; Holland R; de Koning HJ; Broeders MJM; Verbeek ALM
Ann Oncol; 2013 Oct; 24(10):2501-2506. PubMed ID: 23788759
[TBL] [Abstract][Full Text] [Related]
4. Re-attendance after false-positive screening mammography: a population-based study in the Netherlands.
Setz-Pels W; Duijm LE; Coebergh JW; Rutten M; Nederend J; Voogd AC
Br J Cancer; 2013 Oct; 109(8):2044-50. PubMed ID: 24052045
[TBL] [Abstract][Full Text] [Related]
5. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
[TBL] [Abstract][Full Text] [Related]
6. Re-attendance at biennial screening mammography following a repeated false positive recall.
Klompenhouwer EG; Duijm LE; Voogd AC; den Heeten GJ; Strobbe LJ; Louwman MW; Coebergh JW; Venderink D; Broeders MJ
Breast Cancer Res Treat; 2014 Jun; 145(2):429-37. PubMed ID: 24748569
[TBL] [Abstract][Full Text] [Related]
7. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.
Brett J; Austoker J
J Public Health Med; 2001 Dec; 23(4):292-300. PubMed ID: 11873891
[TBL] [Abstract][Full Text] [Related]
8. Impact of false-positive mammography on subsequent screening attendance and risk of cancer.
McCann J; Stockton D; Godward S
Breast Cancer Res; 2002; 4(5):R11. PubMed ID: 12223128
[TBL] [Abstract][Full Text] [Related]
9. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
Otten JD; Karssemeijer N; Hendriks JH; Groenewoud JH; Fracheboud J; Verbeek AL; de Koning HJ; Holland R
J Natl Cancer Inst; 2005 May; 97(10):748-54. PubMed ID: 15900044
[TBL] [Abstract][Full Text] [Related]
10. Screening outcome in women repeatedly recalled for the same mammographic abnormality before, during and after the transition from screen-film to full-field digital screening mammography.
van Bommel R; Voogd AC; Louwman MW; Strobbe LJ; Venderink D; Duijm LE
Eur Radiol; 2017 Feb; 27(2):553-561. PubMed ID: 27180183
[TBL] [Abstract][Full Text] [Related]
11. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
12. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
Tsuruda KM; Larsen M; Román M; Hofvind S
Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.
McGuinness JE; Ueng W; Trivedi MS; Yi HS; David R; Vanegas A; Vargas J; Sandoval R; Kukafka R; Crew KD
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):446-453. PubMed ID: 29382701
[No Abstract] [Full Text] [Related]
14. The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program.
Roman M; Skaane P; Hofvind S
Eur J Radiol; 2014 Sep; 83(9):1639-44. PubMed ID: 24972452
[TBL] [Abstract][Full Text] [Related]
15. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years.
Moss S; Thomas I; Evans A; Thomas B; Johns L;
Br J Cancer; 2005 Mar; 92(5):949-54. PubMed ID: 15726102
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with false-positive mammography at first screen in an Asian population.
Ho PJ; Bok CM; Ishak HMM; Lim LY; Liu J; Wong FY; Chia KS; Tan MH; Chay WY; Hartman M; Li J
PLoS One; 2019; 14(3):e0213615. PubMed ID: 30856210
[TBL] [Abstract][Full Text] [Related]
18. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use.
Blanchard K; Colbert JA; Kopans DB; Moore R; Halpern EF; Hughes KS; Smith BL; Tanabe KK; Michaelson JS
Radiology; 2006 Aug; 240(2):335-42. PubMed ID: 16864665
[TBL] [Abstract][Full Text] [Related]
19. Effect of false-positive screening mammograms on rescreening in Western Australia.
Sim MJ; Siva SP; Ramli IS; Fritschi L; Tresham J; Wylie EJ
Med J Aust; 2012 Jun; 196(11):693-5. PubMed ID: 22708767
[TBL] [Abstract][Full Text] [Related]
20. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
